๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Transplantation: Pre-emptive CMV therapy versus universal CMV prophylaxis in renal transplant recipients

โœ Scribed by Kelsey, Rebecca

Book ID
115545856
Publisher
Nature Publishing Group
Year
2012
Tongue
English
Weight
181 KB
Volume
8
Category
Article
ISSN
1759-5061

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Prophylaxis for CMV should now replace p
Prophylaxis for CMV should now replace pre-emptive therapy in solid organ transplantation
โœ Gregory D. Hart; Carlos V. Paya ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 101 KB

## Abstract Cytomegalovirus is a significant cause of morbidity and mortality in transplantation. Controversy exists concerning whether prophylactic or preโ€emptive therapy is the optimal strategy for preventing CMV disease. In addition, CMV impacts the transplanted graft, transplant recipient and t

Prophylaxis for CMV should not now repla
Prophylaxis for CMV should not now replace pre-emptive therapy in solid organ transplantation
โœ Vincent C. Emery ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 66 KB

## Abstract Preโ€emptive therapy (PET) initiated on the basis of HCMV positivity in the blood using sensitive methods such as PCR, nucleic acid sequence based amplification or antigenaemia offers several advantages for the management of HCMV infection. These include the ability to target antiviral d